Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Changes in causes of acute gastroenteritis in the United Kingdom over 15 years: microbiologic findings from 2 prospective, population-based studies of infectious intestinal disease.

Tam CC, O'Brien SJ, Tompkins DS, Bolton FJ, Berry L, Dodds J, Choudhury D, Halstead F, Iturriza-Gómara M, Mather K, Rait G, Ridge A, Rodrigues LC, Wain J, Wood B, Gray JJ; IID2 Study Executive Committee.

Clin Infect Dis. 2012 May;54(9):1275-86. doi: 10.1093/cid/cis028. Epub 2012 Mar 12.

2.
3.

Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice.

Tam CC, Rodrigues LC, Viviani L, Dodds JP, Evans MR, Hunter PR, Gray JJ, Letley LH, Rait G, Tompkins DS, O'Brien SJ; IID2 Study Executive Committee.

Gut. 2012 Jan;61(1):69-77. doi: 10.1136/gut.2011.238386. Epub 2011 Jun 27.

4.

Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study).

O'Brien SJ, Rait G, Hunter PR, Gray JJ, Bolton FJ, Tompkins DS, McLauchlin J, Letley LH, Adak GK, Cowden JM, Evans MR, Neal KR, Smith GE, Smyth B, Tam CC, Rodrigues LC.

BMC Med Res Methodol. 2010 May 5;10:39. doi: 10.1186/1471-2288-10-39.

5.
6.

Serotypes, intimin subtypes, and antimicrobial resistance patterns of atypical enteropathogenic Escherichia coli isolated in England from 1993 to 1996.

Jenkins C, Smith HR, Lawson AJ, Willshaw GA, Cheasty T, Wheeler JG, Tompkins DS.

Eur J Clin Microbiol Infect Dis. 2006 Jan;25(1):19-24.

PMID:
16402227
7.
8.

The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode.

Cumberland P, Sethi D, Roderick PJ, Wheeler JG, Cowden JM, Roberts JA, Rodrigues LC, Hudson MJ, Tompkins DS; IID Study Executive.

Epidemiol Infect. 2003 Jun;130(3):453-60.

9.

Point source outbreaks of Campylobacter jejuni infection--are they more common than we think and what might cause them?

Gillespie IA, O'Brien SJ, Adak GK, Tam CC, Frost JA, Bolton FJ, Tompkins DS; Campylobacter Sentinel Surveillance Scheme Collaborators.

Epidemiol Infect. 2003 Jun;130(3):367-75.

10.

Vero cytotoxin-producing Escherichia coli in a study of infectious intestinal disease in England.

Evans J, Wilson A, Willshaw GA, Cheasty T, Tompkins DS, Wheeler JG, Smith HR.

Clin Microbiol Infect. 2002 Mar;8(3):183-6.

11.

Is it really food poisoning?

Wheeler JG, Cowden JM, Rodrigues LC, Roderick PJ, Tompkins DS.

Lancet. 2001 Dec 22-29;358(9299):2171-2. No abstract available.

PMID:
11784666
12.

The study of infectious intestinal disease in England: risk factors for cases of infectious intestinal disease with Campylobacter jejuni infection.

Rodrigues LC, Cowden JM, Wheeler JG, Sethi D, Wall PG, Cumberland P, Tompkins DS, Hudson MJ, Roberts JA, Roderick PJ.

Epidemiol Infect. 2001 Oct;127(2):185-93.

13.

A study of infectious intestinal disease in England: risk factors associated with group A rotavirus in children.

Sethi D, Cumberland P, Hudson MJ, Rodrigues LC, Wheeler JG, Roberts JA, Tompkins DS, Cowden JM, Roderick PJ.

Epidemiol Infect. 2001 Feb;126(1):63-70.

14.

A deadly thorn: a case of imported melioidosis.

Torrens JK, McWhinney PH, Tompkins DS.

Lancet. 1999 Mar 20;353(9157):1016. No abstract available.

PMID:
10459941
15.

Effect of clarithromycin and omeprazole therapy on the diversity and stability of genotypes of Helicobacter pylori from duodenal ulcer patients.

Owen RJ, Slater ER, Gibson J, Lorenz E, Tompkins DS.

Microb Drug Resist. 1999 Summer;5(2):141-6.

PMID:
10432275
16.

A study of infectious intestinal disease in England: microbiological findings in cases and controls.

Tompkins DS, Hudson MJ, Smith HR, Eglin RP, Wheeler JG, Brett MM, Owen RJ, Brazier JS, Cumberland P, King V, Cook PE.

Commun Dis Public Health. 1999 Jun;2(2):108-13. Erratum in: Commun Dis Public Health 1999 Sep;2(3):222.

PMID:
10402744
17.

A study of infectious intestinal disease in England: plan and methods of data collection.

Sethi D, Wheeler JG, Cowden JM, Rodrigues LC, Sockett PN, Roberts JA, Cumberland P, Tompkins DS, Wall PG, Hudson MJ, Roderick PJ.

Commun Dis Public Health. 1999 Jun;2(2):101-7.

PMID:
10402743
18.
19.

Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

Moayyedi P, Ragunathan PL, Mapstone N, Axon AT, Tompkins DS.

J Gastroenterol. 1998;33 Suppl 10:62-5.

PMID:
9840021
20.

Use of an amplified-fragment length polymorphism technique to fingerprint and differentiate isolates of Helicobacter pylori.

Gibson JR, Slater E, Xerry J, Tompkins DS, Owen RJ.

J Clin Microbiol. 1998 Sep;36(9):2580-5.

21.

Relevance of antibiotic sensitivities in predicting failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori.

Moayyedi P, Ragunathan PL, Mapstone N, Axon AT, Tompkins DS.

J Gastroenterol. 1998 Apr;33(2):160-3.

PMID:
9605943
22.

Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin.

Tompkins DS, Perkin J, Smith C.

Helicobacter. 1997 Dec;2(4):185-7.

PMID:
9421121
23.

Do patients need to fast for a 13C-urea breath test?

Moayyedi P, Braunholtz D, Heminbrough E, Clough M, Tompkins DS, Mapstone NP, Mason S, Dowell AC, Richards ID, Chalmers DM, Axon AT.

Eur J Gastroenterol Hepatol. 1997 Mar;9(3):275-7.

PMID:
9096429
24.

Randomised double blind controlled study of recurrence of gastric ulcer after treatment for eradication of Helicobacter pylori infection.

Axon AT, O'Moráin CA, Bardhan KD, Crowe JP, Beattie AD, Thompson RP, Smith PM, Hollanders FD, Baron JH, Lynch DA, Dixon MF, Tompkins DS, Birrell H, Gillon KR.

BMJ. 1997 Feb 22;314(7080):565-8.

25.

Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.

Moayyedi P, Langworthy H, Shanahan K, Tompkins DS, Dixon MF, Chalmers DM, Axon AT.

Helicobacter. 1996 Jun;1(2):71-4.

PMID:
9398880
26.

Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori.

Crabtree JE, Xiang Z, Lindley IJ, Tompkins DS, Rappuoli R, Covacci A.

J Clin Pathol. 1995 Oct;48(10):967-9.

27.

Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.

Moayyedi P, Sahay P, Tompkins DS, Axon AT.

Eur J Gastroenterol Hepatol. 1995 Sep;7(9):835-40.

PMID:
8574714
28.

Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype.

Crabtree JE, Covacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S, Lindley IJ, Rappuoli R.

J Clin Pathol. 1995 Jan;48(1):41-5.

29.

A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.

Amyes SG, Baird DR, Crook DW, Gillespie SH, Howard AJ, Oppenhiem BA, Pedler SJ, Paull A, Tompkins DS, Lawrie SA.

J Antimicrob Chemother. 1994 Nov;34(5):639-48.

PMID:
7706159
30.

Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy.

Moayyedi P, Tompkins DS, Axon AT.

Lancet. 1994 Oct 8;344(8928):1016-7. No abstract available.

PMID:
7802823
31.

CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines.

Crabtree JE, Farmery SM, Lindley IJ, Figura N, Peichl P, Tompkins DS.

J Clin Pathol. 1994 Oct;47(10):945-50.

32.

Adaptation of Helicobacter pylori to aerobic growth.

Tompkins DS, Dave J, Mapstone NP.

Eur J Clin Microbiol Infect Dis. 1994 May;13(5):409-12.

PMID:
8070455
33.

Methicillin resistant staphylococcal infection. Nursing homes act as reservoir.

Goodall B, Tompkins DS.

BMJ. 1994 Jan 1;308(6920):58. No abstract available.

34.

Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer.

Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN, Morgan AG.

Gut. 1993 Oct;34(10):1339-43.

35.

Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR.

Mapstone NP, Lynch DA, Lewis FA, Axon AT, Tompkins DS, Dixon MF, Quirke P.

J Clin Pathol. 1993 Jun;46(6):540-3.

36.

Clinical value of microbiological investigations in general practice.

Tompkins DS, Shannon AM.

Br J Gen Pract. 1993 Apr;43(369):155-8.

37.

PCR identification of Helicobacter pylori in faeces from gastritis patients.

Mapstone NP, Lynch DA, Lewis FA, Axon AT, Tompkins DS, Dixon MF, Quirke P.

Lancet. 1993 Feb 13;341(8842):447. No abstract available.

PMID:
8094221
38.

Expression of 120 kilodalton protein and cytotoxicity in Helicobacter pylori.

Crabtree JE, Figura N, Taylor JD, Bugnoli M, Armellini D, Tompkins DS.

J Clin Pathol. 1992 Aug;45(8):733-4.

39.

Effect of physical environment on survival of Helicobacter pylori.

West AP, Millar MR, Tompkins DS.

J Clin Pathol. 1992 Mar;45(3):228-31.

40.

Fatal cryptosporidiosis in association with Sheehan's syndrome.

Tompkins DS, Batman PA.

Br J Gen Pract. 1991 Dec;41(353):519. No abstract available.

41.

Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals.

Ho SA, Hoyle JA, Lewis FA, Secker AD, Cross D, Mapstone NP, Dixon MF, Wyatt JI, Tompkins DS, Taylor GR, et al.

J Clin Microbiol. 1991 Nov;29(11):2543-9.

42.

Immune responses to Helicobacter pylori in children with recurrent abdominal pain.

Crabtree JE, Mahony MJ, Taylor JD, Heatley RV, Littlewood JM, Tompkins DS.

J Clin Pathol. 1991 Sep;44(9):768-71.

43.

Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, Rathbone BJ.

Lancet. 1991 Aug 10;338(8763):332-5.

PMID:
1677696
44.

Isolation of Helicobacter pylori from frozen gastric biopsy specimens.

Tompkins DS, Rotowa NA.

Lancet. 1991 Jul 27;338(8761):253. No abstract available.

PMID:
1676805
45.
46.

Survival of Helicobacter pylori in water and saline.

West AP, Millar MR, Tompkins DS.

J Clin Pathol. 1990 Jul;43(7):609. No abstract available.

47.

Ascorbic acid in the human stomach.

Sobala GM, Schorah CJ, Sanderson M, Dixon MF, Tompkins DS, Godwin P, Axon AT.

Gastroenterology. 1989 Aug;97(2):357-63.

PMID:
2744355
48.

Isoelectric focusing of ureases from Campylobacter pylori and related organisms.

Tompkins DS, Millar MR, West AP.

J Clin Microbiol. 1988 Dec;26(12):2678-9.

49.
50.

Spore tests for low temperature steam with formaldehyde sterilizers.

Tompkins DS, Dunn M, Cade ME.

J Hosp Infect. 1988 Oct;12(3):237. No abstract available.

PMID:
2904466

Supplemental Content

Loading ...
Support Center